News Archives - Page 7 of 14 - Alzheon | Preserving Future Memories

6 Jul, 2021

Breaking News in the Field of Alzheimer’s: Alzheon Announces First Patient Dosed in Phase 3 Trial

alzheon2024-08-05T18:53:38-04:00July 6th, 2021|Tags: Generation Bold|

23 Jun, 2021

Paper Highlights Role of Neurotoxic Soluble Amyloid Oligomers in Alzheimer’s Pathogenesis

alzheon2021-06-25T15:19:06-04:00June 23rd, 2021|Tags: BioSpace.com|

23 Jun, 2021

Alzheon Completes Patient Enrollment in Phase 2 Biomarker Trial of ALZ-801 Oral Tablet in APOE4 Carriers with Alzheimer’s Disease

alzheon2024-08-05T19:54:22-04:00June 23rd, 2021|Tags: Press Release Tag|

23 Jun, 2021

Peer-Reviewed Scientific Publication Demonstrates Central Role of Neurotoxic Soluble Amyloid Oligomers in Driving Alzheimer’s Pathogenesis

alzheon2024-08-12T10:14:03-04:00June 23rd, 2021|Tags: Press Release Tag|

11 Jun, 2021

Treating Alzheimer’s Disease: Alzheon Moves Forward With Trials For New Medication

alzheon2024-08-05T18:47:48-04:00June 11th, 2021|Tags: Fox Business|

10 Jun, 2021

Investor interest in Alzheimer’s ‘changed on the dime’ following FDA’s decision on Biogen’s aducanumab

alzheon2024-07-29T15:38:07-04:00June 10th, 2021|Tags: Fierce Biotech|

9 Jun, 2021

“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugs

alzheon2024-07-29T15:23:18-04:00June 9th, 2021|Tags: Techcrunch.com|

8 Jun, 2021

Here are the 9 biggest biotech winners after the FDA took an entirely new approach to approve Biogen’s Alzheimer’s drug

alzheon2024-07-29T15:37:37-04:00June 8th, 2021|Tags: Insider|

7 Jun, 2021

FDA approval of debated Alzheimer’s drug is tremendous for society: Alzheon CEO

alzheon2024-08-05T18:57:02-04:00June 7th, 2021|Tags: BNN|

4 Jun, 2021

Alzheon Announces First Patient Dosed in APOLLOE4 Phase 3 Trial of Oral ALZ 801 in Patients with Early Alzheimer’s Disease

alzheon2024-08-26T10:57:03-04:00June 4th, 2021|Tags: Press Release Tag|